This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Jacqueline Lesperance: Innovator in Cancer Research
Introduction
Jacqueline Lesperance is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on developing methods and compositions that can enhance the effectiveness of Growth Factor Inhibitors in treating cancer.
Latest Patents
Jacqueline Lesperance holds 1 patent for her invention titled "Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS." This patent outlines various methods for overcoming or diminishing Growth Factor Inhibitor resistance in cells. It also includes methods for increasing the growth-inhibiting effectiveness of a Growth Factor inhibitor on a cell, as well as re-sensitizing a cell to a Growth Factor Inhibitor. The invention is particularly relevant for tumor cells, cancer cells, or dysfunctional cells.
Career Highlights
Lesperance is affiliated with the University of California, where she continues her research and development efforts. Her work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.
Collaborations
Jacqueline collaborates with esteemed colleagues, including David A. Cheresh and Laetitia Seguin, who contribute to her research initiatives and enhance the scope of her work.
Conclusion
Jacqueline Lesperance is a dedicated inventor whose innovative approaches to cancer treatment are paving the way for new therapeutic strategies. Her contributions to the field are invaluable and hold promise for future advancements in medical science.